Kraig Biocraft Laboratories (KBLB) Notes Payables (2013 - 2026)

Kraig Biocraft Laboratories has disclosed Notes Payables across 12 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Notes Payables fell 7.73% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $1.5 million (down 7.73% YoY), while the FY2025 annual figure was $1.5 million, down 7.73% from the prior year.
• Notes Payables came in at $1.5 million for Q2 2026 at Kraig Biocraft Laboratories, roughly flat from $1.5 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $1.6 million in Q1 2022 to a low of $1.5 million in Q4 2025.
• Average Notes Payables over 5 years is $1.6 million, with a median of $1.6 million recorded in 2022.
• Year-over-year, Notes Payables changed 0.0% in 2023 and retreated 7.73% in 2025.
• Over 5 years, Notes Payables stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then slipped by 7.73% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $1.5 million in Q2 2026, $1.5 million in Q4 2025, and $1.6 million in Q3 2025.